Skip to main content
. Author manuscript; available in PMC: 2025 May 1.
Published in final edited form as: Lancet Neurol. 2024 May;23(5):487–499. doi: 10.1016/S1474-4422(24)00083-8

Table 1:

Summary of characteristics of the Pick’s disease series and controls.

Variable N Median (25th percentile, 75th percentile) or No. (%) (N=338)
Pick’s disease series
    Age at death (years) 69 (65, 74)
    Age of disease onset (years) 58 (54, 65)
    Disease duration (years) 10 (8, 13)
    Sex
       Male 205 (60.7%)
       Female 133 (39.3%)
    Clinical diagnosis 328
       FTD 262 (79.9%)
       AD 40 (12.2%)
       CBS 15 (4.6%)
       PSP 2 (0.6%)
       Dementia not otherwise specified 8 (2.4%)
       Vascular dementia 1 (0.3%)
    Behavioral impairment during illness 232 188 (81.0%)
    Language impairment during illness 221 153 (69.2%)
    Parkinsonism during illness 206 56 (27.2%)
    Braak NFT stage 176
       0 87 (49.4%)
       I 29 (16.5%)
       II 28 (15.9%)
       III 11 (6.3%)
       IV 10 (5.7%)
       V 4 (2.3%)
       VI 7 (4.0%)
    Thal amyloid phase 177
       0 100 (56.5%)
       1 32 (18.1%)
       2 18 (10.2%)
       3 15 (8.5%)
       4 7 (4.0%)
       5 5 (2.8%)
    Brain weight (g) 296 980 (880, 1083)
Controls
    Age at blood draw (years) 69 (61, 75)
    Sex
       Male 611 (46.6%)
       Female 701 (53.4%)

FTD=frontotemporal dementia; bvFTD=behavioral variant FTD; PPA=primary progressive aphasia; AD=Alzheimer’s disease; CBS=corticobasal syndrome; PSP=progressive supranuclear palsy; VaD=vascular dementia; NFT=neurofibrillary tangle.

Age at disease onset and disease duration information was not available for 29 individuals in the Pick’s disease series.